Related Experiment Video
Updated: May 16, 2026
08:52
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
Disease modelling using induced pluripotent stem cells: status and prospects.
1Institute of Medical Biology, #06-06 Immunos, Singapore.
Summary
Induced pluripotent stem cells (iPSCs) offer custom cell production for drug discovery and disease modeling. While iPSCs show disease phenotypes, challenges remain for their full application in studying complex disorders.
Area of Science:
- Stem cell biology
- Genetics
- Drug discovery
Background:
- Human somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs).
- iPSCs enable the creation of patient-specific cells for research.
- Disease phenotypes are observable in iPSCs and their derivatives.
Purpose of the Study:
- To review recent advances in iPSC technology for disease modeling.
- To discuss challenges in applying iPSCs to study human disorders.
- To highlight the potential of iPSCs in drug discovery and personalized medicine.
Main Methods:
- Literature review of recent studies on iPSC technology.
- Analysis of iPSC applications in disease modeling.
- Discussion of current limitations and future directions.
Main Results:
- iPSCs derived from patients exhibit disease-specific phenotypes.
- In vitro reversal of disease phenotypes using drugs has been demonstrated.
- Significant challenges persist in the widespread application of iPSCs for disease modeling.
Conclusions:
- iPSC technology holds great promise for disease modeling and drug discovery.
- Overcoming technical and practical challenges is crucial for realizing the full potential of iPSCs.
- Further research is needed to refine iPSC applications in understanding and treating human diseases.
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.